تحميل...
Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines
Although a combination of platinum- and taxane-based chemotherapy is recommended for at least 70% patients with ovarian cancer as treatment subsequent to surgery, the initial response to the chemotherapy is not durable and tumors become resistant. Histone deacetylase and proteasome inhibitors are no...
محفوظ في:
| الحاوية / القاعدة: | Oncol Lett |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
D.A. Spandidos
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5452869/ https://ncbi.nlm.nih.gov/pubmed/28588720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6032 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|